vs
Healthpeak Properties(DOC)与亨斯迈(HUN)财务数据对比。点击上方公司名可切换其他公司
亨斯迈的季度营收约是Healthpeak Properties的1.9倍($1.4B vs $719.4M),Healthpeak Properties净利率更高(73.2% vs -7.1%,领先80.3%),Healthpeak Properties同比增速更快(3.1% vs -6.7%),Healthpeak Properties自由现金流更多($357.0M vs $19.0M),过去两年Healthpeak Properties的营收复合增速更高(8.9% vs -4.0%)
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
亨斯迈公司是总部位于美国得克萨斯州伍德兰兹的全球化化工巨头,面向消费端与工业客户生产、销售各类化工产品,主营聚氨酯、高性能材料及胶粘剂,客户覆盖宝马、通用电气、雪佛龙、宝洁、联合利华等知名品牌。目前公司在全球25个国家设有60余处生产、研发及运营基地,员工约7000人。
DOC vs HUN — 直观对比
营收规模更大
HUN
是对方的1.9倍
$719.4M
营收增速更快
DOC
高出9.7%
-6.7%
净利率更高
DOC
高出80.3%
-7.1%
自由现金流更多
DOC
多$338.0M
$19.0M
两年增速更快
DOC
近两年复合增速
-4.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $719.4M | $1.4B |
| 净利润 | $114.0M | $-96.0M |
| 毛利率 | — | 12.1% |
| 营业利润率 | 17.4% | -4.4% |
| 净利率 | 73.2% | -7.1% |
| 营收同比 | 3.1% | -6.7% |
| 净利润同比 | 2406.4% | 31.9% |
| 每股收益(稀释后) | $0.16 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOC
HUN
| Q4 25 | $719.4M | $1.4B | ||
| Q3 25 | $705.9M | $1.5B | ||
| Q2 25 | $694.3M | $1.5B | ||
| Q1 25 | $702.9M | $1.4B | ||
| Q4 24 | $698.0M | $1.5B | ||
| Q3 24 | $700.4M | $1.5B | ||
| Q2 24 | $695.5M | $1.6B | ||
| Q1 24 | $606.6M | $1.5B |
净利润
DOC
HUN
| Q4 25 | $114.0M | $-96.0M | ||
| Q3 25 | $-117.1M | $-25.0M | ||
| Q2 25 | $31.7M | $-158.0M | ||
| Q1 25 | $42.8M | $-5.0M | ||
| Q4 24 | $4.5M | $-141.0M | ||
| Q3 24 | $85.9M | $-33.0M | ||
| Q2 24 | $146.0M | $22.0M | ||
| Q1 24 | $6.7M | $-37.0M |
毛利率
DOC
HUN
| Q4 25 | — | 12.1% | ||
| Q3 25 | 58.6% | 14.0% | ||
| Q2 25 | 60.2% | 12.5% | ||
| Q1 25 | 61.1% | 14.3% | ||
| Q4 24 | 60.3% | 12.9% | ||
| Q3 24 | 60.0% | 15.2% | ||
| Q2 24 | 60.6% | 15.4% | ||
| Q1 24 | 59.8% | 13.7% |
营业利润率
DOC
HUN
| Q4 25 | 17.4% | -4.4% | ||
| Q3 25 | 9.2% | 0.4% | ||
| Q2 25 | 5.7% | -8.2% | ||
| Q1 25 | 7.7% | 3.0% | ||
| Q4 24 | -2.2% | -4.3% | ||
| Q3 24 | 14.1% | 2.7% | ||
| Q2 24 | 22.3% | 2.2% | ||
| Q1 24 | 3.7% | -2.6% |
净利率
DOC
HUN
| Q4 25 | 73.2% | -7.1% | ||
| Q3 25 | -16.6% | -1.7% | ||
| Q2 25 | 4.6% | -10.8% | ||
| Q1 25 | 6.1% | -0.4% | ||
| Q4 24 | 0.7% | -9.7% | ||
| Q3 24 | 12.3% | -2.1% | ||
| Q2 24 | 21.0% | 1.4% | ||
| Q1 24 | 1.1% | -2.5% |
每股收益(稀释后)
DOC
HUN
| Q4 25 | $0.16 | $-0.56 | ||
| Q3 25 | $-0.17 | $-0.14 | ||
| Q2 25 | $0.05 | $-0.92 | ||
| Q1 25 | $0.06 | $-0.03 | ||
| Q4 24 | $0.02 | $-0.82 | ||
| Q3 24 | $0.12 | $-0.19 | ||
| Q2 24 | $0.21 | $0.13 | ||
| Q1 24 | $0.01 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $429.0M |
| 总债务越低越好 | $9.8B | $2.0B |
| 股东权益账面价值 | $7.5B | $2.8B |
| 总资产 | $20.3B | $7.0B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.73× |
8季度趋势,按日历期对齐
现金及短期投资
DOC
HUN
| Q4 25 | $467.5M | $429.0M | ||
| Q3 25 | $91.0M | $468.0M | ||
| Q2 25 | $89.4M | $399.0M | ||
| Q1 25 | $70.6M | $334.0M | ||
| Q4 24 | $119.8M | $340.0M | ||
| Q3 24 | $180.4M | $330.0M | ||
| Q2 24 | $106.9M | $335.0M | ||
| Q1 24 | $101.8M | $552.0M |
总债务
DOC
HUN
| Q4 25 | $9.8B | $2.0B | ||
| Q3 25 | $9.1B | $2.0B | ||
| Q2 25 | $9.0B | $2.0B | ||
| Q1 25 | $8.9B | $2.0B | ||
| Q4 24 | $8.7B | $1.8B | ||
| Q3 24 | $8.6B | $1.9B | ||
| Q2 24 | $8.6B | $1.9B | ||
| Q1 24 | $8.8B | $2.1B |
股东权益
DOC
HUN
| Q4 25 | $7.5B | $2.8B | ||
| Q3 25 | $7.6B | $2.8B | ||
| Q2 25 | $7.9B | $2.8B | ||
| Q1 25 | $8.2B | $3.0B | ||
| Q4 24 | $8.4B | $3.0B | ||
| Q3 24 | $8.6B | $3.1B | ||
| Q2 24 | $8.8B | $3.1B | ||
| Q1 24 | $8.9B | $3.2B |
总资产
DOC
HUN
| Q4 25 | $20.3B | $7.0B | ||
| Q3 25 | $19.6B | $7.1B | ||
| Q2 25 | $19.8B | $7.1B | ||
| Q1 25 | $19.8B | $7.2B | ||
| Q4 24 | $19.9B | $7.1B | ||
| Q3 24 | $20.0B | $7.3B | ||
| Q2 24 | $20.2B | $7.3B | ||
| Q1 24 | $20.5B | $7.6B |
负债/权益比
DOC
HUN
| Q4 25 | 1.31× | 0.73× | ||
| Q3 25 | 1.20× | 0.73× | ||
| Q2 25 | 1.14× | 0.72× | ||
| Q1 25 | 1.08× | 0.66× | ||
| Q4 24 | 1.04× | 0.62× | ||
| Q3 24 | 1.00× | 0.60× | ||
| Q2 24 | 0.98× | 0.62× | ||
| Q1 24 | 0.99× | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.3B | $76.0M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $19.0M |
| 自由现金流率自由现金流/营收 | 49.6% | 1.4% |
| 资本支出强度资本支出/营收 | 124.4% | 4.2% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $116.0M |
8季度趋势,按日历期对齐
经营现金流
DOC
HUN
| Q4 25 | $1.3B | $76.0M | ||
| Q3 25 | $315.0M | $196.0M | ||
| Q2 25 | $363.5M | $91.0M | ||
| Q1 25 | $279.4M | $-74.0M | ||
| Q4 24 | $1.1B | $153.0M | ||
| Q3 24 | $318.2M | $129.0M | ||
| Q2 24 | $316.2M | $46.0M | ||
| Q1 24 | $152.6M | $-65.0M |
自由现金流
DOC
HUN
| Q4 25 | $357.0M | $19.0M | ||
| Q3 25 | — | $153.0M | ||
| Q2 25 | — | $54.0M | ||
| Q1 25 | — | $-110.0M | ||
| Q4 24 | $333.7M | $102.0M | ||
| Q3 24 | — | $88.0M | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | — | $-107.0M |
自由现金流率
DOC
HUN
| Q4 25 | 49.6% | 1.4% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | -7.8% | ||
| Q4 24 | 47.8% | 7.0% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | -7.3% |
资本支出强度
DOC
HUN
| Q4 25 | 124.4% | 4.2% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | 105.6% | 3.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.9% |
现金转化率
DOC
HUN
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | — | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | 2.09× | ||
| Q1 24 | 22.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
HUN
| Diversified | $897.0M | 66% |
| Specialty | $231.0M | 17% |
| Performance Products | $113.0M | 8% |
| Advanced Materials | $61.0M | 5% |
| Related Party Customers | $19.0M | 1% |
| Other | $12.0M | 1% |